re: after close chart Results are due in November, but the...

re: after close chart Results are due in November, but the trials finish in September. there should be an announcement to confirm the completion of the trials.

The trials have been in progress since January, with each batch of patients tested for 3 months, results must known within the company. I don't think they would locked away the earlier results without analysis. The fact that the trials are still progressing indicates a degree of positiveness.

I think the share price will run a bit at conclusion of 2b trials in a few weeks time. I'm expecting $1.70.

Regards

TDF